Evidence map›Paper›PMID 26901429›Full record

ArticleBiomaterials2016

One-pot synthesis of pH-responsive hybrid nanogel particles for the intracellular delivery of small interfering RNA.

Sm Z Khaled, Armando Cevenini, Iman K Yazdi, Alessandro Parodi, Michael Evangelopoulos, Claudia Corbo, Shilpa Scaria, Ye Hu, Seth G Haddix, Bruna Corradetti and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Biomaterials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 78 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Hydrogels and nanogels: effectiveness in dermal applications.Beilstein journal of nanotechnology · 2025
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Theranostic biomaterials for tissue engineering.Current opinion in biomedical engineering · 2021
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Trends towards Biomimicry in Theranostics.Nanomaterials (Basel, Switzerland) · 2018
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Sm Z Khaled *Department of Regenerative Medicine: Center for Biomimetic Medicine, Houston Methodist Research Institute, Houston, Texas, 77030 United States.
Armando Cevenini *Department of Regenerative Medicine: Center for Biomimetic Medicine, Houston Methodist Research Institute, Houston, Texas, 77030 United States.
Iman K Yazdi *Department of Regenerative Medicine: Center for Biomimetic Medicine, Houston Methodist Research Institute, Houston, Texas, 77030 United States.
Alessandro ParodiDepartment of Regenerative Medicine: Center for Biomimetic Medicine, Houston Methodist Research Institute, Houston, Texas, 77030 United States.
Michael EvangelopoulosDepartment of Regenerative Medicine: Center for Biomimetic Medicine, Houston Methodist Research Institute, Houston, Texas, 77030 United States.
Claudia CorboDepartment of Regenerative Medicine: Center for Biomimetic Medicine, Houston Methodist Research Institute, Houston, Texas, 77030 United States.
Shilpa ScariaDepartment of Regenerative Medicine: Center for Biomimetic Medicine, Houston Methodist Research Institute, Houston, Texas, 77030 United States.
Ye HuDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, Texas, 77030 United States.
Seth G HaddixDepartment of Regenerative Medicine: Center for Biomimetic Medicine, Houston Methodist Research Institute, Houston, Texas, 77030 United States.
Bruna CorradettiDepartment of Regenerative Medicine: Center for Biomimetic Medicine, Houston Methodist Research Institute, Houston, Texas, 77030 United States.
Francesco SalvatoreCEINGE-Biotecnologie Avanzate, s.c.a r.l., Naples, 80145 Italy.
Ennio TasciottiDepartment of Regenerative Medicine: Center for Biomimetic Medicine, Houston Methodist Research Institute, Houston, Texas, 77030 United States.
Houston Methodist · USIstituti di Ricovero e Cura a Carattere Scientifico · ITMarche Polytechnic University · ITSDN Istituto di Ricerca Diagnostica e Nucleare · ITUniversity of Naples Federico II · IT

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Leukocyte Membrane Cloaked Carriers to Target and Overcome Tumor VasculatureR21CA173579 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI TASCIOTTI, ENNIO · 2013 to 2014
$371k
NCI NIH HHS 1R21CA173579-01A1NCI NIH HHS P30 CA016672NCI NIH HHS R21 CA173579
6 · The paper itself

Abstract

This report describes a novel, one-pot synthesis of hybrid nanoparticles formed by a nanostructured inorganic silica core and an organic pH-responsive hydrogel shell. This easy-to-perform, oil-in-water emulsion process synthesizes fluorescently-doped silica nanoparticles wrapped within a tunable coating of cationic poly(2-diethylaminoethyl methacrylate) hydrogel in one step. Transmission electron microscopy and dynamic light scattering analysis demonstrated that the hydrogel-coated nanoparticles are uniformly dispersed in the aqueous phase. The formation of covalent chemical bonds between the silica and the polymer increases the stability of the organic phase around the inorganic core as demonstrated by thermogravimetric analysis. The cationic nature of the hydrogel is responsible for the pH buffering properties of the nanostructured system and was evaluated by titration experiments. Zeta-potential analysis demonstrated that the charge of the system was reversed when transitioned from acidic to basic pH and vice versa. Consequently, small interfering RNA (siRNA) can be loaded and released in an acidic pH environment thereby enabling the hybrid particles and their payload to avoid endosomal sequestration and enzymatic degradation. These nanoparticles, loaded with specific siRNA molecules directed towards the transcript of the membrane receptor CXCR4, significantly decreased the expression of this protein in a human breast cancer cell line (i.e., MDA-MB-231). Moreover, intravenous administration of siRNA-loaded nanoparticles demonstrated a preferential accumulation at the tumor site that resulted in a reduction of CXCR4 expression.

Indexed as

RNAi TherapeuticsAnimalsBreastBreast NeoplasmsCationsCell Line, TumorDelayed-Action PreparationsFemaleHumansMethacrylatesMice, NudeNanoparticlesPolymersReceptors, CXCR4RNA, Small InterferingSilicon DioxideCationsCXCR4 protein, humanDelayed-Action Preparationsdiethylaminoethyl methacrylateMethacrylatesPolymersReceptors, CXCR4RNA, Small InterferingSilicon DioxideCancer therapyLysosomal escapeNanoparticlespH-responsive polymersiRNA delivery

Identifiers

PMID26901429
PMCPMC4785811
OpenAlexW2282962776

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.